Inovio Announces First Patient Dosed in Trial to Determine PENNVAX-GP’s Ability to Induce Remission…
Inovio Pharmaceuticals, Inc. announced that the first participant has been dosed with PENNVAX-GP in a randomized clinical trial that will evaluate its ability to drive remission of HIV…
Read More...
Read More...
